Utipro plus AF
against acute and recurrent cystitis


The advantages of Utipro plus AF at a glance
Utipro plus AF stoppt schMore than half of all women suffer from urinary tract infection at least once in their lives. Of these, 20 –30 % have recurrent relapses.¹ Utipro plus is an innovative treatment approach for the control and prevention of uncomplicated urinary tract infections.nell & schützt stark vor Harnwegsinfekten
When do you use Utipro plus AF and what does Utipro plus AF do?
The medical device is used to control and prevent urinary tract infections caused by pathogens such as E. coli and other bacteria.
80 % of all urinary tract infections are caused by intestinal bacteria. ²
Cystitis (inflammation of the bladder) is almost always caused by intestinal bacteria that ascend from the intestine into the bladder via the urethra and cause painful inflammation of the bladder mucosa there. Due to the shorter urethra, women are affected more frequently than men are.

Symptom control starts in the intestine!
Utipro plus is currently the only treatment approach that effectively combats the source of infection in the intestine by means of a protective film while at the same time allowing symptom control in the bladder by means of hibiscus and propolis. Utipro plus thus gets to the root of the troubles, namely in the intestine.
Dosage
In case of acute infection
- From the onset of the first symptoms
- 2 × 1 capsule for 5 days (every 12 hours), with or without antibiotics
In case of recurring infections
- For prevention of relapses
- 1 × 1 capsule for at least 15 consecutive days per month, over several cycles

Ingredients
Combination of xyloglucan, (porcine) gelatine, propolis, Hibiscus sabdariffa, silicon dioxide, magnesium stearate (vegetable) and corn starch
References:
https://www.gesundheit.gv.at/krankheiten/nieren-harnblase/blasenentzuendung/harnwegsinfekt
Grabe M et al. Guidelines on Urological Infections. European Association of Urology, 2009.
For the effects and possible adverse effects of this medical device, please consult the patient information leaflet (package insert) or talk to your doctor or pharmacist. The product information is referring to the current Austrian approval.